IGF2 and cervical carcinoma: Another study looking at the relationship between LOI and promoter usage in cervical carcinoma [52] found an exclusive usage of p1 in tumor tissues with underlying IGF2 LOI but not in those tumors with maintenance of IGF2 imprinting (MOI).